萊茵生物(002166.SZ)控股股東及其一致行動人解質3041.05萬股及再質押1950萬股
格隆匯4月16日丨萊茵生物(002166.SZ)公佈,公司董事會近日接到公司控股股東及其一致行動人蔣安明的通知,獲悉控股股東秦本軍將其質押給國海證券的3041.05萬股股份辦理了解除質押手續,控股股東的一致行動人蔣安明將其持有的公司股份辦理了1950萬股股票質押式回購交易。
截至目前,公司控股股東及其一致行動人累計質押股份數量為1.13億股,佔其所持公司股份數量的68.48%。
蔣安明及其一致行動人未來半年內到期的質押股份累計數量為1899.9萬股,佔其所持公司股份的11.56%,佔公司總股本的3.36%,對應融資金額5000萬元。蔣安明及其一致行動人具備足夠的資金償付能力,還款資金來源包括個人薪酬、上市公司股票分紅、對外投資收益及其它現金收入等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.